Garcia Marino
Insider CIK 1669866 · SGYP EVP and Chief Strategy Officer · DNTH CEO AND PRESIDENT, Director · AGMB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AGMB AgomAb Therapeutics NV | A Award deriv | 2026-09-11 | 2026-09-15 | 57,482 | — | $0 | 57,482 | SEC↗ |
| AGMB AgomAb Therapeutics NV | A Award deriv | 2026-09-11 | 2026-09-15 | 57,482 | — | $0 | 57,482 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise deriv | 2026-08-07 | 2026-08-07 | 126,000 | — | $0 | 160,004 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise deriv | 2026-08-07 | 2026-08-07 | 40,000 | — | $0 | 286,004 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-08-07 | 2026-08-07 | 21,909 | $108.72 | $2.38M | 65,292 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-08-07 | 2026-08-07 | 10,384 | $107.49 | $1.12M | 220,908 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise | 2026-08-07 | 2026-08-07 | 126,000 | $8.44 | $1.06M | 231,292 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise | 2026-08-07 | 2026-08-07 | 40,000 | $8.44 | $337.6K | 105,292 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-08-07 | 2026-08-07 | 23,907 | $108.05 | $2.58M | 197,001 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-08-07 | 2026-08-07 | 104,091 | $107.96 | $11.24M | 87,102 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-08-07 | 2026-08-07 | 800 | $110.76 | $88.6K | 191,292 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-08-07 | 2026-08-07 | 2,536 | $110.02 | $279.0K | 192,092 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-08-07 | 2026-08-07 | 2,373 | $109.10 | $258.9K | 194,628 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise deriv | 2026-08-07 | 2026-08-07 | 126,000 | — | $0 | 160,004 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise deriv | 2026-08-07 | 2026-08-07 | 40,000 | — | $0 | 286,004 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-08-07 | 2026-08-07 | 21,909 | $108.72 | $2.38M | 65,292 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-08-07 | 2026-08-07 | 104,091 | $107.96 | $11.24M | 87,102 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-08-07 | 2026-08-07 | 800 | $110.76 | $88.6K | 191,292 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-08-07 | 2026-08-07 | 2,536 | $110.02 | $279.0K | 192,092 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-08-07 | 2026-08-07 | 2,373 | $109.10 | $258.9K | 194,628 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-08-07 | 2026-08-07 | 23,907 | $108.05 | $2.58M | 197,001 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-08-07 | 2026-08-07 | 10,384 | $107.49 | $1.12M | 220,908 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise | 2026-08-07 | 2026-08-07 | 126,000 | $8.44 | $1.06M | 231,292 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise | 2026-08-07 | 2026-08-07 | 40,000 | $8.44 | $337.6K | 105,292 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise deriv | 2026-03-16 | 2026-03-17 | 5,592 | — | $0 | 269,408 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise deriv | 2026-03-16 | 2026-03-17 | 59,700 | — | $0 | 41 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise | 2026-03-16 | 2026-03-17 | 5,592 | $17.88 | $100.0K | 65,292 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise | 2026-03-16 | 2026-03-17 | 59,700 | $6.70 | $400.0K | 59,700 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise deriv | 2026-03-12 | 2026-03-13 | 122,918 | — | $0 | 59,741 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-03-12 | 2026-03-13 | 900 | $85.53 | $77.0K | 0 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-03-12 | 2026-03-13 | 200 | $83.38 | $16.7K | 900 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-03-12 | 2026-03-13 | 12,796 | $82.60 | $1.06M | 1,100 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise | 2026-03-12 | 2026-03-13 | 122,918 | $6.70 | $823.6K | 122,918 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-03-12 | 2026-03-13 | 43,505 | $80.69 | $3.51M | 79,413 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-03-12 | 2026-03-13 | 65,517 | $81.74 | $5.36M | 13,896 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2026-02-03 | 2026-02-04 | 355,000 | — | $0 | 355,000 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2025-09-30 | 2025-10-03 | 120,000 | — | $0 | 120,000 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2025-02-03 | 2025-02-04 | 340,000 | — | $0 | 340,000 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2024-05-23 | 2024-05-28 | 243,000 | — | $0 | 243,000 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2024-01-24 | 2024-01-26 | 275,000 | — | $0 | 275,000 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2018-01-05 | 2018-01-09 | 280,000 | — | $0 | 1,010,000 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2016-06-24 | 2016-06-27 | 200,000 | — | $0 | 730,000 | SEC↗ |